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Introduction: The neuronal ceroid lipofuscinoses constitute a group of fatal inherited lysosomal storage diseases
that manifest in profound neurodegeneration in the CNS. Visual impairment usually is an early symptom and
selective degeneration of retinal neurons has been described in patients suffering from distinct disease subtypes.
We have previously demonstrated that palmitoyl protein thioesterase 1 deficient (Ppt1-/-) mice, a model of the
infantile disease subtype, exhibit progressive axonal degeneration in the optic nerve and loss of retinal ganglion
cells, faithfully reflecting disease severity in the CNS. Here we performed spectral domain optical coherence
tomography (OCT) in Ppt1-/- and ceroid lipofuscinosis neuronal 3 deficient (Cln3-/-) mice, which are models of
infantile and juvenile neuronal ceroid lipofuscinosis, respectively, in order to establish a non-invasive method to
assess retinal alterations and monitor disease severity in vivo.
Results: Blue laser autofluorescence imaging revealed increased accumulation of autofluorescent storage material
in the inner retinae of 7-month-old Ppt1-/- and of 16-month-old Cln3-/- mice in comparison with age-matched control
littermates. Additionally, optical coherence tomography demonstrated reduced thickness of retinae in knockout mice
in comparison with age-matched control littermates. High resolution scans and manual measurements allowed for
separation of different retinal composite layers and revealed a thinning of layers in the inner retinae of both mouse
models at distinct ages. OCT measurements correlated well with subsequent histological analysis of the same retinae.
Conclusions: These results demonstrate the feasibility of OCT to assess neurodegenerative disease severity in mouse
models of neuronal ceroid lipofuscinosis and might have important implications for diagnostic evaluation of disease
progression and therapeutic efficacy in patients. Moreover, the non-invasive method allows for longitudinal studies in
experimental models, reducing the number of animals used for research.
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The assessment of neuronal perturbation and neurode-
generation is of critical importance in many diseases of
the central nervous system (CNS), as it strongly corre-
lates with permanent neurological disability. Therefore,
minimally- or non-invasive techniques for unbiased de-
termination of neuronal perturbation are not only useful
for diagnosis, but even more so for monitoring disease
progression and efficacy of therapeutic interventions.
An ideal CNS-related target to monitor these issues is
the eye with its easy accessibility. Consequently, optical
coherence tomography (OCT) has emerged as an im-
portant diagnostic tool not only to monitor ophthalmo-
logical disorders but also other neurological diseases of
the CNS including multiple sclerosis, Alzheimer’s and
Parkinson’s disease [1-3]. The neuronal ceroid lipuscinoses
(CLN diseases; NCLs), a group of fatal neurodegenerative
lysosomal storage diseases, may comprise additional mor-
bidities that can be diagnosed and followed up by OCT, as
the visual system is often affected early during pathogen-
esis and might reflect disease stage and progression in
other regions of the CNS.
The different CLN subtypes are caused by mutations
in distinct CLN genes encoding proteins important for
lysosomal function and cellular homeostasis [4]. Defi-
ciencies in these proteins result in the accumulation of
lipofuscin-like autofluorescent storage material (also
termed ceroid) in the cytoplasm of neurons and other
cell types and a selective loss of neurons in the brain
and retina, eventually culminating in disability and early
death [5,6].
Deficiencies in the soluble lysosomal enzyme palmitoyl
protein thioesterase 1 (PPT1) result in the devastating
infantile form of the disease (CLN1 disease) and muta-
tions in ceroid lipofuscinosis neuronal 3 (CLN3), a
transmembrane protein of uncertain function, are cause
of the most common juvenile subtype (CLN3 disease)
[7]. In both subtypes, visual impairment is often one of
the first symptoms, and retinal degeneration has been
described in patients, but the cause and progression of
visual deficits is not well understood [8-11].
Mouse models of CLN1 and CLN3 disease have been
generated using different genetic strategies and authen-
tically mimic human disease aspects [12-16]. Retinal dys-
function and retinal degeneration have previously been
investigated in these mouse models. Taken together,
histological and electrophysiological studies in Ppt1 and
Cln3 mutant mice have demonstrated that deficits
mainly occur in the optic nerve and inner retinal layers
at distinct ages [17-23]. Accordingly, impairment of vis-
ual acuity also affects mouse models of CLN1 and CLN3
at distinct ages [18,24].
In order to monitor retinal degeneration in a non-
invasive manner, we performed spectral domain opticalcoherence tomography (OCT) in Ppt1-/- and Cln3-/- mice.
By combining confocal laser fundus imaging and cross-
sectional OCT analysis with high resolution, we demon-
strate an accumulation of autofluorescent storage material
and a thinning of distinct retinal layers indicative of neu-
rodegeneration. We show that neuron loss in both mouse
models predominantly affects the inner retina and confirm
that these features occur later in Cln3-/- mice than in
Ppt1-/- mice.
In general, the presented method can be used to perform
non-invasive and longitudinal studies in mouse models of
neurological diseases and might have important implica-
tions for diagnosis and monitoring of disease progression
and therapeutic interventions.
Material and methods
Animals
Mice were kept at the animal facility of the Department
of Neurology, University of Wuerzburg, under barrier
conditions and at a constant cycle of 12 h in the light
(< 300 lux) and 12 h in the dark. All animal experiments
were approved by the Government of Lower Franconia,
Germany.
Ppt1-deficient (Ppt1-/-) mice with disruption of exon 9
[13] and age-matched control (Ppt1+/+) littermates were
on a uniform C57BL/6 genetic background. Cln3-deficient
(Cln3-/-) mice with disruption of exons 2-6 and most of
exon 1 [16] and age-matched control littermates (Cln3+/+)
were on a Sv/129 genetic background. Genotypes were de-
termined by conventional PCR using isolated DNA from
tail biopsies following previously published protocols
[13,16]. Mice were screened for the confounding Rd8 mu-
tation in the Crb1 gene as described [25]. Both mouse
lines did not carry the described mutation.
We did not detect significant differences in the mea-
sured parameters between 18-month-old C57BL/6 and
Sv/129 wildtype controls (not shown).
Spectral domain Optical Coherence Tomography (OCT)
Mice were anesthetized by intraperitoneal injection of
ketamine and xylazine, and their pupils were dilated by
topical administration of 1 drop of 0.5% tropicamide eye
drops (Mydrum; Bausch & Lomb) before image acquisi-
tion. Air-corneal interface refraction and corneal de-
hydration were prevented by applying artificial tears
(Corneregel® Fluid; Bausch & Lomb) and a custom-made
polymethylmethacrylate hard contact lens (afocal, curva-
ture: 1.7 mm, diameter: 3.2 mm; Cantor + Nissel). Mouse
eyes were subjected to OCT imaging with a commercially
available device (Spectralis OCT; Heidelberg Engineering)
reaching a digital resolution of 3.9 μm and a measurable
thickness change of 1 μm [26]. To adjust for the optical
qualities of the mouse eye, we used a +25 diopter add-on
lens (Heidelberg Engineering) that was placed directly in
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proprietary software package (Heidelberg Eye Explorer,
HEYEX, version 1.7.1; Heidelberg Engineering). The par-
ameter for length of the reference pathway was manually
adjusted using the “OCT debug window” to correct for
the optical length of the scanning pathway with additional
lenses. The combination of confocal scanning laser retinal
fundus imaging and OCT allows for automatic real-timeFigure 1 Experimental setup and description of image acquisition set
polymethylmethacrylate hard contact lens (arrow) and a +25 diopter add-o
of the animal to allow imaging centered on the optic disc. C-G: Representa
Ppt1+/+ mouse. C: infrared fundus image (IR), D: blue laser autofluorescence
(49 B-scans), G: OCT peripapillary circle scan. Field of view, automatic real-time
images; HR, high resolution. For clarification, 3D-visualizations of OCT scan
in C, D and to 100 μm in fundus images in E, F, G.tracking (ART) of eye movements and real-time averaging
of up to 100 images, profoundly reducing speckle noise.
After the imaging procedure animals were kept warm, the
contact lens was removed and cleaned and eyes were cov-
ered with Corneregel® (Bausch & Lomb) until awakening
of the mice. Resultant image files were used for analysis in
the proprietary software or exported and processed using
Photoshop CS3 (Adobe Systems). The analyzed retinaltings. A: Additional equipment for analysis of mouse eyes included a
n lens. B: Depiction of the custom-built rodent mount and positioning
tive examples of the different imaging modes exemplarily shown for a
fundus image (BAF), E: OCT star scan (6 B-scans), F: OCT volume scan
tracking (ART) and resolution settings are indicated in the corresponding
s are depicted. Scale bars correspond to 50 μm of subtended retina
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assuming that 30° field of view is subtended by 900 μm of
retina.
For quantification of retinal thickness based on high-
resolution OCT volume scans, we used the proprietary
software. Briefly, each volume scan consisted of 49 high
resolution B-scans with ART 20 recorded at 20° × 20°
field-of-view centered on the optic disc. Volume scans
were used to calculate interpolated retinal thickness
maps. A segmented circular OCT grid was centered on
the optic disc and retina thickness was calculated by
averaging the values of the 4 outer areas.
Retinal composite layers were measured in high reso-
lution OCT peripapillary circle scans with ART 100 cen-
tered on the optic disc. An investigator unaware of the
genotype of the respective mice performed manual mea-
surements at 600× and 1:1 μm view in the proprietary
software. The following composite layers were well
recognizable in all scans and therefore the retina was sep-
arated into 4 layers: 1) nerve fiber layer (NFL), ganglion
cell layer (GCL) and inner plexiform layer (IPL); 2) innerFigure 2 Funduscopy of 7-month-old Ppt1+/+ and Ppt1-/- mice. A: IR fu
appearance of Ppt1-/- mice in comparison with controls (n = 4 per group). O
funduscopy demonstrated accumulation of hyperfluorescent profiles in the
Scale bars correspond to 50 μm of subtended retina.nuclear layer (INL); 3) outer plexiform layer (OPL), outer
nuclear layer (ONL) and inner/outer segments of photore-
ceptors (IOS); 4) retinal pigment epithelium (RPE) and
choriocapillary complex (CC). Additionally, a combination
of NFL, GCL, IPL and INL was defined as inner retina
and a combination of OPL, ONL, IOS, RPE and CC was
defined as outer retina. Five to ten measurements of each
layer were performed along the width of the circle scan,
avoiding measurements on top of major blood vessels.
Histology, electron microscopy and immunofluorescence
Mice were euthanized and transcardially perfused with
PBS containing heparin and subsequently with 2% para-
formaldehyde (PFA) in PBS. Optic nerves and eyes were
postfixed in the same solution for 1 h, dehydrated in
30% sucrose and frozen in OCT medium. 10 μm-thick
cryo-sections of optic nerves and retinae were prepared
and stored at -20°C until use.
Eyes were enucleated and postfixed in 4% PFA in PBS
for 15 minutes and retinal flat mounts were prepared.
Cresyl violet staining and quantification of Nissl-positivendus images revealed no obvious differences in general retinal
ptic disc and major blood vessels were well recognizable. B: BAF
inner retinal layers of Ppt1-/- mice in comparison with Ppt1+/+ mice.
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ously published protocols [18].
Immunohistochemical labeling of NeuN, Brn3a and
non-phosphorylated neurofilaments in cryo-sections was
performed as previously described [18].
For electron microscopy and correlation of OCT and
histology, eyes with attached optic nerves were enucle-
ated and postfixed in 4% PFA and 2% glutaraldehyde in
cacodylate buffer over night. Tissue was osmicated,
dehydrated and embedded in Spurr’s medium as de-
scribed [18]. Semi-thin (0.5 μm) and ultra-thin (70 nm)
sections through the optic nerve head were prepared
and stained with methylene blue or lead citrate, respect-
ively. Micrographs were acquired using an Axiophot 2
light microscope (Zeiss) with an attached CCD camera
(Visitron Systems) or a Leo 906 E electron microscope
(Zeiss) with a ProScan Slow Scan CCD camera. Mea-
surements of the 4 defined retinal composite layers were
taken on both sides of the optic nerve head mirroring
the position of peripapillary OCT circle scans.Figure 3 Funduscopy of 16-month-old Cln3+/+ and Cln3-/- mice. A: IR f
appearance of Cln3-/- mice compared with controls (n = 4 per group). How
groups showed brighter overall appearance of retinae in comparison with
vessels were well recognizable. B: Accumulation of hyperfluorescent profile
mice was obvious in BAF fundus images. Scale bars correspond to 50 μm oStatistical analysis
Statistical analysis was performed using PASW Statistics
18 (SPSS, IBM) software. Shapiro-Wilk test was used to
check for normal distribution of data. Parametric compar-
isons between thickness values of age-matched control
mice and knockout mice were made by unpaired two-
tailed Student’s t-test. Correlation of thickness measure-
ments by OCT versus histology was assessed by Pearson’s
correlation analysis.
Results
In vivo assessment of autofluorescent storage material
and retinal thickness
We investigated mouse retinae using the commercially
available Spectralis OCT device with slight modifications. A
custom-made polymethylmethacrylate hard contact lens
(Cantor +Nissel) and a +25 diopter add-on lens (Heidelberg
Engineering) were used to adjust for optical qualities of
the mouse eye (Figure 1A). A custom-made detachable
and adjustable mount was built and anaesthetized miceundus images revealed no obvious differences in general retinal
ever, based on the different genetic background, both Cln3 genotype
Ppt1 genotype groups (see Figure 2A). Optic disc and major blood
s in the inner retinal layers of Cln3-/- mice in comparison with Cln3+/+
f subtended retina.
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of the mount for imaging centered on the optic disc
(Figure 1B). Examination was performed during ap-
proximately 10 to 15 minutes comprising the acquisi-
tion settings exemplarily shown for a Ppt1+/+ mouse
(Figure 1C-G) at high resolution (HR).
In order to investigate retinal alterations in a mouse
model of CLN1 disease, we analyzed 7-month-old Ppt1-/-
mice and age-matched Ppt1+/+ control littermates. At this
age, our previous histological examination of retinal flat
mounts demonstrated significant loss of retinal ganglion
cells [18]. Infrared (IR) fundus images revealed no obvious
alterations in general appearance of retinae from Ppt1-/-
mice compared with controls (Figure 2A). However, blue
laser autofluorescence (BAF) fundus imaging revealed
many spots of hyperfluorescence in Ppt1-/- mice. Based on
the focal plane and localization related to blood vessels,
we concluded that these profiles accumulated in the inner
retinal layers of Ppt1-/- mice. Such hyperfluorescent pro-
files were rarely detected in Ppt1+/+ mice (Figure 2B).
Similarly, Cln3-/- mice were investigated as a model of
CLN3 disease. Since these mice were reported to show
retinal pathology at advanced age [20,22], we investigatedFigure 4 Assessment of retina thickness in OCT volume scans. A: Repr
7-month-old Ppt1+/+ and Ppt1-/- mice and 16-month-old Cln3+/+ and Cln3-/
and retina thickness was calculated by averaging the values of the 4 outer
retina. B: Retina thickness was significantly reduced in Ppt1-/- and Cln3-/- mi
Student’s t-test. * P < 0.05.16-month-old Cln3-/- mice and Cln3+/+ control litter-
mates. Again, IR fundus images were not obviously differ-
ent between the knockout and control mice (Figure 3A),
while frequent hyperfluorescent spots were always observed
in the inner retinal layers of Cln3-/- but not Cln3+/+
mice (Figure 3B).
As a next step, the retinal thickness of 7-month-old
Ppt1-/- and 16-month-old Cln3-/- mice and age-matched
control littermates was determined using thickness maps
generated from high-resolution volume scans (Figure 4A).
The outer values from circular OCT grid subfields with
the center located on the optic disc were averaged. In both
Ppt1-/- and Cln3-/- mice, the mean retinal thickness was
significantly reduced in comparison with age-matched
control littermates (Figure 4B).
To further delineate thinning of retinal layers, manual
measurements were performed on high resolution peripa-
pillary circle scans by an investigator unaware of the geno-
type of the respective mice. The retina was subdivided
into 4 composite layers as described in Material and
Methods (Figure 5A). Inner and outer retina thickness
were compared between 7-month-old Ppt1+/+ and Ppt1-/-
mice, revealing a significant thinning of the inner retina inesentative interpolated thickness maps from retinal volume scans of
- mice. A segmented circular OCT grid was centered on the optic disc
areas (yellow filling). Scale bars correspond to 70 μm of subtended
ce compared to age-matched control littermates (n = 4 per group).
Figure 5 Separation of peripapillary OCT circle scans from 7-month-old Ppt1+/+ and Ppt1-/- mice into composite layers. A: Representative
excerpts of OCT circle scans from Ppt1+/+ and Ppt1-/- mice with indication of the defined layers. Scale bar: 200 μm. B: Inner but not outer retina
thickness was significantly reduced in Ppt1-/- mice (n = 4 per group). Student’s t-test. **P < 0.01. C: Significant thinning was detected in NFL/GCL/
IPL and INL of Ppt1-/- mice, but not in other retinal layers. Student’s t-test. * P < 0.05, **P < 0.01. n.s. = not significant.
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cant thinning of both layer 1 (NFL/GCL/IPL) and 2 (INL),
while layer 3 (OPL/ONL/IOS) showed a non-significant
trend to thinning in Ppt1-/- mice in comparison with con-
trols (Figure 5C).
Similar results were obtained with 16-month-old Cln3-/-
and age-matched Cln3+/+ mice. We detected a significant
thinning of the inner retinal layers (layers 1 and 2) and a
non-significant tendency for layer 3 (Figure 6A-C).
In summary, according to our investigations by BAF
fundus imaging and OCT, accumulation of autofluores-
cent storage material and thinning of retinal layers as a
marker of neuronal loss, are typical features of the inner
retinal layers in Ppt1-/- and Cln3-/- mice.Comparison of OCT with histological analysis
To correlate the thickness values measured by OCT with
values gained by histological examination, the investigated
mice were dissected few days after initial OCT imaging.
The corresponding retinae were processed for light and
electron microscopy and the 4 defined composite layers
were measured in retinal sections at similar positions as
peripapillary circle scans by an investigator blinded to the
genotype. Corroborating our findings, histological measure-
ments and OCT measurements showed highly significantPearson’s correlation with coefficients of determination
(R2) close to 1 (Figure 7A).
The distribution of storage material in the retina was
investigated by electron microscopy. Cytoplasmic inclu-
sions in retinal cells presented as typical granular osmio-
philic deposits in Ppt1-/- mice and as fingerprint profiles
in Cln3-/- mice (Figure 7B), confirming previously de-
scribed ultrastructural differences of the storage material
[13,16]. In both Ppt1-/- and Cln3-/- mice, the amount of
storage material was clearly increased in comparison with
age-matched control littermates showing little or no stor-
age material (Figure 7B). The storage material was mostly
observed in perikarya in the retinal ganglion cell layer and,
at lower amounts, in perikarya in the inner nuclear layer
of both knockout models. Cells in the outer nuclear layer
or inner and outer segments of photoreceptors showed
no obviously increased accumulation of storage material
(Figure 7B). Thus, both techniques, OCT and EM reveal
a spatially corresponding deposition of storage material,
confirming the reliability of the non-invasive autofluores-
cence imaging approach.
Axonal perturbation and loss of retinal ganglion cells in
Cln3-/- mice
OCT imaging indicated significant degenerative alter-
ations in the inner retina of Cln3-/- mice at advanced age.
Figure 6 Composite layer separation of peripapillary OCT circle scans from 16-month-old Cln3+/+ and Cln3-/- mice. A: Representative
excerpts of OCT circle scans from Cln3+/+ and Cln3-/- mice with indication of the defined layers. Scale bar: 200 μm. B: There was a significant
reduction of the inner but not outer retina thickness in Cln3-/- mice (n = 4 per group). Student’s t-test. *** P < 0.001. C: Significant thinning was
detected in NFL/GCL/IPL and INL of Cln3-/- mice, but not in other retinal layers. Student’s t-test. ** P < 0.01. n.s. = not significant.
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optic nerve pathology in Cln3-/- mice [22] and reminiscent
of Ppt1-/- mice in which we have reported significant loss
of retinal ganglion cells [18]. To confirm the observed
thinning as a sign of neurodegeneration also in this model,
we investigated 18-month-old Cln3-/- mice and age-
matched Cln3+/+ littermates regarding integrity of retinal
ganglion cells.
Retinal flat mounts were prepared, stained with cresyl
violet, and Nissl-positive neurons were quantified in the
retinal ganglion cell layer. We detected a significant loss
of retinal ganglion cells in Cln3-/- mice in comparison with
age-matched Cln3+/+ control littermates (Figure 8A). Loss
of retinal ganglion cells was also confirmed by immuno-
histochemical detection of the neuronal marker NeuN
and the transcription factor Brn3a in cryo-sections. For
both markers, Cln3-/- mice presented with fewer immuno-
reactive cells in the ganglion cell layer in comparison with
Cln3+/+ mice (Figure 8B,C).
Our previous investigation of Ppt1-/- mice revealed that
impaired axonal integrity and axonal degeneration precede
neuronal loss and are accompanied by axonal swelling and
spheroid formation [18]. We therefore analyzed optic nerves
of Cln3-/- mice at 18 months of age by electron microscopy
and immunohistochemistry against non-phosphorylated
neurofilaments (Figure 8D,E) and detected axonal spheroidsthat appeared morphologically similar to those in younger
Ppt1-/- mice. Immunohistochemical quantification of these
spheroids confirmed a significantly increased amount of
SMI32-positive degenerating axons in optic nerves of
Cln3-/- mice in comparison with Cln3+/+ mice, in which
such spheroids were rarely detected (Figure 8F).
Discussion
To our knowledge, this is the first study using OCT as a
method for non-invasive assessment of retinal degeneration
in mouse models of infantile and juvenile neuronal ceroid
lipofuscinosis. Blue laser autofluorescence fundus imaging
faithfully revealed the typical accumulation of autofluores-
cent storage material in the inner retinal layers of both
knockout mouse models. Moreover, OCT scans revealed a
thinning of the retina in both models, confirming the his-
tologically observed retinal degeneration at distinct age of
onset, as reported previously [18-20,22]. Delineation of
different retinal composite layers by non-biased manual
measurements demonstrated that this thinning is predom-
inantly due to a reduced thickness of the inner retinal
layers, correlating well with subsequent histological evalu-
ation and investigation of retinal ganglion cell survival and
axonal integrity.
These findings display some common features in retinae
of Ppt1-/- and Cln3-/- mice. A predominant dysfunction of
Figure 7 Comparison of OCT with histological analysis. A: Representative excerpt of an OCT B-scan through the optic nerve head and a
corresponding micrograph of a 0.5 μm thick semi-thin section. Scale bars, 200 μm in OCT scan and 100 μm in micrograph. Thickness measurements of
composite layers acquired by OCT correlated significantly with values measured in histological sections (n = 4 per group). Pearson’s correlation. Cln3+/+,
P < 0.01. Cln3-/-, P < 0.01. Ppt1+/+, P < 0.001. Ppt1-/-, P < 0.01. Coefficients of determination (R2) are indicated for the different groups. B: Electron
micrographs of retinal layers from 7-month-old Ppt1-/- and 16-month-old Cln3+/+ and Cln3-/- mice. Accumulation of granular osmiophilic deposits
(GRODs; arrows) was mostly observed in cells in the GCL and INL of Ppt1-/- mice, but not in Ppt1+/+ (not shown) or Cln3+/+ controls. Similarly, fingerprint
profiles (FPs; arrowheads) were predominantly detected in cells in the GCL and INL of Cln3-/- mice, but not in Ppt1+/+ or Cln3+/+ mice. Scale bars:
0.2 μm and 5 μm.
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cated by electroretinographic analysis of Ppt1 and Cln3
mutant mice, as mostly b-wave amplitudes were affected
[17,21,23]. However, a trend towards thinning was also
seen in the outer retina, not reaching statistical signifi-
cance. Based on our histological examinations, this lack of
statistical significance is most likely not due to a limited
resolution of the OCT technique, but might rather be due
to the limited sample sizes and/or the age of the mice in-
vestigated. Of note, in mouse models of other CLN diseasevariants, as for instance in Cln6mutant mice, a predomin-
ant degeneration of the outer retina has been demon-
strated [28]. Similarly, there is significant variety in the
presentation of retinal defects also in patients suffering
from distinct CLN forms [29]. It remains to be determined
why there seems to be a predominant degeneration of dis-
tinct retinal layers in models of different CLN disease types.
Some disparities regarding the progression of neuronal loss
in specific brain regions have also been described in models
of different CLN disease forms in other studies [30].
Figure 8 Loss of retinal ganglion cells and axonal perturbation in optic nerves of Cln3-/- mice. A: Cresyl violet staining of retinal flat mount
preparations and quantification of Nissl + retinal ganglion cells in 18-month-old Cln3+/+ and Cln3-/- mice (n = 4 per group). Scale bar: 50 μm. B:
NeuN and C: Brn3a immunohistochemistry on retinal sections from 18-month-old Cln3+/+ and Cln3-/- mice. Scale bar, 30 μm. A loss of NeuN + or
Brn3a + retinal ganglion cells in Cln3-/- mice was obvious. D: Representative electron micrograph of optic nerve cross-sections from 18-month-old
Cln3-/- mice. Axonal spheroids with accumulation of organelles and dense bodies were frequently observed. E: Immunohistochemistry using
antibodies against non-phosphorylated neurofilaments (SMI32; brownish precipitate) in longitudinal optic nerve sections of 18-month-old Cln3-/- mice
visualizes axonal spheroids. Scale bar: 30 μm. F: Quantification revealed that SMI32+ axonal spheroids are barely detectable in optic nerves of Cln3+/+
mice but accumulate in 18-month-old Cln3-/- mice (n = 4 per group). Student’s t-test. ***P < 0.001.
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storage material and neurodegeneration has important
implications for longitudinal imaging in animal studies.
Our previous observations have shown that loss of ret-
inal ganglion cells is a reliable indicator of neuron loss
in other brain regions and that the retina can be used as
a surrogate tissue to monitor disease severity at least in
a model of CLN1 disease [18]. This also seems to be
valid for Cln3-/- mice, as retinal alterations (this study
and unpublished observations) and regional brain atrophy[31] occur only at advanced age. Moreover, visualization
of autofluorescent storage material might provide a good
read-out to validate strategies aimed at correcting the pri-
mary disease cause, such as enzyme replacement therapy.
Thus, OCT seems to be an ideal tool to measure disease
progression and to assess efficacy of putative therapeutic
approaches in rodent models. According to presently un-
published and preliminary observations, OCT analysis is
of sufficient sensitivity to confirm the previously described
ameliorating effect of Rag1 deficiency regarding retinal
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feasibility of this approach to assess disease-modifying
strategies. The consequent option of the present tech-
nique to examine the same animal at different time-points
allows for exact determination of kinetics of disease pro-
gression and other disease-specific parameters. In addition
to the presented substantial advantages of the technique,
non-invasive imaging reduces biological variation (refine-
ment) and eventually numbers of experimental animals
(reduction), which has important ethical implications re-
garding research in animal models.
Moreover, the presented method might be of high
relevance for studies or trials in patients. Non-invasive
imaging techniques revealing typical alterations associ-
ated with CLN diseases (storage material, neurodegen-
eration) might not only guide in diagnostics, but are
also important to determine disease status and severity
and control efficacy of therapeutic interventions. As the
perspectives for such treatment approaches become in-
creasingly more promising the demand for efficient non-
invasive techniques to judge their efficacy is constantly
growing [32,33].
Finally, non-invasive assessment of specific retinal
layers appears to emerge as a powerful tool to monitor
disease severity also in other more common neurological
disorders and their corresponding models. For example,
in line with our findings, thinning of inner retinal layers
is also associated with a loss of retinal ganglion cells in a
mouse model of multiple sclerosis [34] and is a typical
feature in multiple sclerosis and Alzheimer’s patients
[3,35,36]. There is already a wide spectrum of diseases
and corresponding animal models that can be monitored
using OCT, and future studies will most likely extend
this spectrum to include more neurodegenerative disor-
ders of primarily non-ophthalmologic origin.Conclusions
We demonstrate the feasibility of OCT to assess distinct
alterations related to disease severity in the retina of two
mouse models of neuronal ceroid lipofuscinosis in vivo.
Reflecting accompanying conventional histological inves-
tigations, both accumulation of autofluorescent storage
material and retinal thinning indicative of neurodegener-
ation mainly occur in the inner retina of the analyzed
mice. The non-invasive method allows for longitudinal
studies in experimental models, reducing the number of
animals used for research. Moreover, it might have im-
portant implications for diagnostic evaluation of disease
progression and therapeutic efficacy in patients. The
presented method might emerge as an important tool to
monitor neuronal alterations not only in CLN diseases,
but in many neurological disorders characterized by
widespread axonal perturbation in the CNS.Abbreviations
CLN: Ceroid lipofuscinosis neuronal; PPT1: Palmitoyl protein thioesterase 1;
OCT: Optical coherence tomography; BAF: Blue laser autofluorescence;
IR: Infrared; ART: Automatic real-time tracking; NFL: Nerve fiber layer;
GCL: Ganglion cell layer; IPL: Inner plexiform layer; INL: Inner nuclear layer;
OPL: Outer plexiform layer; ONL: Outer nuclear layer; IOS: Inner/outer
segments of photoreceptors; RPE: Retinal pigment epithelium;
CC: Choriocapillary complex.
Competing interests
The authors declare that they have no competing interests.
Authors’ contributions
JG designed the study and wrote the manuscript receiving conceptual input
and revision by MB and RM. JG carried out the experiments, acquired and
analyzed data and was herein supported by DS. All authors read and
approved the final manuscript.
Acknowledgements
The authors are grateful to Heinrich Blazyca, Silke Loserth and Bettina Meyer
for expert technical assistance and to Helga Brünner, Anja Weidner,
Jacqueline Schreiber and Jennifer Bauer for attentive care of mice.
This work was supported by the NCL-Foundation, Hamburg, the Interdisciplinary
Centre for Clinical Research (IZKF) of the University of Wuerzburg and local funds
of the University of Wuerzburg. The authors thank Novartis, Basel, and the Roman,
Marga and Mareille Sobek-Foundation, Renningen, for generous support.
This publication was funded by the German Research Foundation (DFG)
and the University of Wuerzburg in the funding programme Open
Access Publishing.
Author details
1Department of Neurology, Developmental Neurobiology, University of
Wuerzburg, Josef-Schneider-Str. 11, D-97080 Wuerzburg, Germany.
2Department of Neurology, University of Wuerzburg, Josef-Schneider-Str. 11,
D-97080 Wuerzburg, Germany.
Received: 17 April 2014 Accepted: 30 April 2014
Published: 10 May 2014
References
1. Adhi M, Duker JS: Optical coherence tomography–current and future
applications. Curr Opin Ophthalmol 2013, 24(3):213–221.
2. Simao LM: The contribution of optical coherence tomography in
neurodegenerative diseases. Curr Opin Ophthalmol 2013, 24(6):521–527.
3. Frohman EM, Fujimoto JG, Frohman TC, Calabresi PA, Cutter G, Balcer LJ:
Optical coherence tomography: a window into the mechanisms of
multiple sclerosis. Nat Clin Pract Neurol 2008, 4(12):664–675.
4. Kollmann K, Uusi-Rauva K, Scifo E, Tyynela J, Jalanko A, Braulke T: Cell
biology and function of neuronal ceroid lipofuscinosis-related proteins.
Biochim Biophys Acta 2013, 1832(11):1866–1881.
5. Palmer DN, Barry LA, Tyynela J, Cooper JD: NCL disease mechanisms.
Biochim Biophys Acta 2013, 1832(11):1882–1893.
6. Anderson GW, Goebel HH, Simonati A: Human pathology in NCL. Biochim
Biophys Acta 2013, 1832(11):1807–1826.
7. Warrier V, Vieira M, Mole SE: Genetic basis and phenotypic correlations of
the neuronal ceroid lipofusinoses. Biochim Biophys Acta 2013, 1832
(11):1827–1830.
8. Haltia M: The neuronal ceroid-lipofuscinoses: from past to present.
Biochim Biophys Acta 2006, 1762(10):850–856.
9. Haltia M, Goebel HH: The neuronal ceroid-lipofuscinoses: a historical
introduction. Biochim Biophys Acta 2013, 1832(11):1795–1800.
10. Bozorg S, Ramirez-Montealegre D, Chung M, Pearce DA: Juvenile neuronal
ceroid lipofuscinosis (JNCL) and the eye. Surv Ophthalmol 2009, 54(4):463–471.
11. Weleber RG, Gupta N, Trzupek KM, Wepner MS, Kurz DE, Milam AH:
Electroretinographic and clinicopathologic correlations of retinal
dysfunction in infantile neuronal ceroid lipofuscinosis (infantile Batten
disease). Mol Genet Metab 2004, 83(1–2):128–137.
12. Jalanko A, Vesa J, Manninen T, von Schantz C, Minye H, Fabritius AL, Salonen T,
Rapola J, Gentile M, Kopra O, Peltonen L: Mice with Ppt1Deltaex4 mutation
replicate the INCL phenotype and show an inflammation-associated loss of
interneurons. Neurobiol Dis 2005, 18(1):226–241.
Groh et al. Acta Neuropathologica Communications 2014, 2:54 Page 12 of 12
http://www.actaneurocomms.org/content/2/1/5413. Gupta P, Soyombo AA, Atashband A, Wisniewski KE, Shelton JM, Richardson JA,
Hammer RE, Hofmann SL: Disruption of PPT1 or PPT2 causes neuronal
ceroid lipofuscinosis in knockout mice. Proc Natl Acad Sci U S A 2001,
98(24):13566–13571.
14. Cotman SL, Vrbanac V, Lebel LA, Lee RL, Johnson KA, Donahue LR, Teed AM,
Antonellis K, Bronson RT, Lerner TJ, MacDonald ME: Cln3(Deltaex7/8) knock-in
mice with the common JNCL mutation exhibit progressive neurologic
disease that begins before birth. Hum Mol Genet 2002, 11(22):2709–2721.
15. Katz ML, Shibuya H, Liu PC, Kaur S, Gao CL, Johnson GS: A mouse gene
knockout model for juvenile ceroid-lipofuscinosis (Batten disease).
J Neurosci Res 1999, 57(4):551–556.
16. Mitchison HM, Bernard DJ, Greene ND, Cooper JD, Junaid MA, Pullarkat RK,
de Vos N, Breuning MH, Owens JW, Mobley WC, Gardiner RM, Lake BD,
Taschner PE, Nussbaum RL: Targeted disruption of the Cln3 gene
provides a mouse model for Batten disease. the Batten Mouse Model
Consortium [corrected]. Neurobiol Dis 1999, 6(5):321–334.
17. Griffey M, Macauley SL, Ogilvie JM, Sands MS: AAV2-mediated ocular gene
therapy for infantile neuronal ceroid lipofuscinosis. Mol Ther 2005,
12(3):413–421.
18. Groh J, Kuhl TG, Ip CW, Nelvagal HR, Sri S, Duckett S, Mirza M, Langmann T,
Cooper JD, Martini R: Immune cells perturb axons and impair neuronal
survival in a mouse model of infantile neuronal ceroid lipofuscinosis.
Brain 2013, 136(Pt 4):1083–1101.
19. Lei B, Tullis GE, Kirk MD, Zhang K, Katz ML: Ocular phenotype in a mouse
gene knockout model for infantile neuronal ceroid lipofuscinosis.
J Neurosci Res 2006, 84(5):1139–1149.
20. Seigel GM, Lotery A, Kummer A, Bernard DJ, Greene ND, Turmaine M,
Derksen T, Nussbaum RL, Davidson B, Wagner J, Mitchison HM: Retinal
pathology and function in a Cln3 knockout mouse model of juvenile
neuronal ceroid lipofuscinosis (batten disease). Mol Cell Neurosci 2002,
19(4):515–527.
21. Staropoli JF, Haliw L, Biswas S, Garrett L, Holter SM, Becker L, Skosyrski S,
Da Silva-Buttkus P, Calzada-Wack J, Neff F, Rathkolb B, Rozman J, Schrewe A,
Adler T, Puk O, Sun M, Favor J, Racz I, Bekeredjian R, Busch DH, Graw J,
Klingenspor M, Klopstock T, Wolf E, Wurst W, Zimmer A, Lopez E, Harati H,
Hill E, Krause DS, et al: Large-scale phenotyping of an accurate genetic
mouse model of JNCL identifies novel early pathology outside the
central nervous system. PLoS One 2012, 7(6):e38310.
22. Weimer JM, Custer AW, Benedict JW, Alexander NA, Kingsley E, Federoff HJ,
Cooper JD, Pearce DA: Visual deficits in a mouse model of Batten disease
are the result of optic nerve degeneration and loss of dorsal lateral
geniculate thalamic neurons. Neurobiol Dis 2006, 22(2):284–293.
23. Katz ML, Johnson GS, Tullis GE, Lei B: Phenotypic characterization of a
mouse model of juvenile neuronal ceroid lipofuscinosis. Neurobiol Dis
2008, 29(2):242–253.
24. Volz C, Mirza M, Langmann T, Jagle H: Retinal function in aging
homozygous cln3 (deltaex7/8) knock-in mice. Adv Exp Med Biol 2014,
801:495–501.
25. Mattapallil MJ, Wawrousek EF, Chan CC, Zhao H, Roychoudhury J, Ferguson TA,
Caspi RR: The Rd8 mutation of the Crb1 gene is present in vendor lines of
C57BL/6 N mice and embryonic stem cells, and confounds ocular induced
mutant phenotypes. Invest Ophthalmol Vis Sci 2012, 53(6):2921–2927.
26. Wolf-Schnurrbusch UE, Ceklic L, Brinkmann CK, Iliev ME, Frey M,
Rothenbuehler SP, Enzmann V, Wolf S: Macular thickness measurements in
healthy eyes using six different optical coherence tomography
instruments. Invest Ophthalmol Vis Sci 2009, 50(7):3432–3437.
27. Leung CK, Lindsey JD, Chen L, Liu Q, Weinreb RN: Longitudinal profile of
retinal ganglion cell damage assessed with blue-light confocal scanning
laser ophthalmoscopy after ischaemic reperfusion injury. Br J Ophthalmol
2009, 93(7):964–968.
28. Mirza M, Volz C, Karlstetter M, Langiu M, Somogyi A, Ruonala MO, Tamm ER,
Jagle H, Langmann T: Progressive retinal degeneration and glial
activation in the CLN6 (nclf) mouse model of neuronal ceroid
lipofuscinosis: a beneficial effect of DHA and curcumin supplementation.
PLoS One 2013, 8(10):e75963.
29. Hainsworth DP, Liu GT, Hamm CW, Katz ML: Funduscopic and
angiographic appearance in the neuronal ceroid lipofuscinoses. Retina
2009, 29(5):657–668.
30. Cooper JD: The neuronal ceroid lipofuscinoses: the same, but different?
Biochem Soc Trans 2010, 38(6):1448–1452.31. Kühl TG, Dihanich S, Wong AMS, Cooper JD: Regional brain atrophy in
mouse models of neuronal ceroid lipofuscinosis: a new rostrocaudal
perspective. J Child Neurol 2013, 28(9):1117–1122.
32. Sarkar C, Chandra G, Peng S, Zhang Z, Liu A, Mukherjee AB:
Neuroprotection and lifespan extension in Ppt1(-/-) mice by NtBuHA:
therapeutic implications for INCL. Nat Neurosci 2013, 16(11):1608–1617.
33. Hawkins-Salsbury JA, Cooper JD, Sands MS: Pathogenesis and therapies for
infantile neuronal ceroid lipofuscinosis (infantile CLN1 disease).
Biochim Biophys Acta 2013, 1832(11):1906–1909.
34. Lidster K, Jackson SJ, Ahmed Z, Munro P, Coffey P, Giovannoni G, Baker MD,
Baker D: Neuroprotection in a novel mouse model of multiple sclerosis.
PLoS One 2013, 8(11):e79188.
35. Syc SB, Saidha S, Newsome SD, Ratchford JN, Levy M, Ford E, Crainiceanu CM,
Durbin MK, Oakley JD, Meyer SA, Frohman EM, Calabresi PA: Optical
coherence tomography segmentation reveals ganglion cell layer pathology
after optic neuritis. Brain 2012, 135(Pt 2):521–533.
36. Paquet C, Boissonnot M, Roger F, Dighiero P, Gil R, Hugon J: Abnormal
retinal thickness in patients with mild cognitive impairment and
Alzheimer’s disease. Neurosci Lett 2007, 420(2):97–99.
doi:10.1186/2051-5960-2-54
Cite this article as: Groh et al.: Non-invasive assessment of retinal
alterations in mouse models of infantile and juvenile neuronal ceroid
lipofuscinosis by spectral domain optical coherence tomography. Acta
Neuropathologica Communications 2014 2:54.Submit your next manuscript to BioMed Central
and take full advantage of: 
• Convenient online submission
• Thorough peer review
• No space constraints or color figure charges
• Immediate publication on acceptance
• Inclusion in PubMed, CAS, Scopus and Google Scholar
• Research which is freely available for redistribution
Submit your manuscript at 
www.biomedcentral.com/submit
